According to latest research study “Blood Gas and Electrolyte Analyzer Market Analysis, Size, Share and Forecast 2022-2023” by IMARC Group, finds that the market reached a value of US$ 1.85 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.76 Billion by 2027, exhibiting a CAGR of 6.70% during 2022-2027.
Blood gas and electrolyte analyzers represent the medical devices customized for determining several parameters in a whole blood sample, including potential hydrogen (pH), blood gas (partial pressure of carbon dioxide and oxygen), metabolites, and electrolytes. In terms of modality, they are available in benchtop and portable models. Blood gas and electrolyte analyzer products are effective in detecting metabolic imbalances and the measurement of renal and cardiac functions. They aid in measuring the acid-base balance of a patient, diabetes, drug consumption, etc. Blood gas and electrolyte analyzer instruments are cost-effective and provide accurate and fast results. Consequently, they find extensive applications across various establishments, such as hospitals, clinics, ambulatory surgical centers, etc.
Request for a Free Sample Copy of This Report: https://www.imarcgroup.com/blood-gas-electrolyte-analyzer-market/requestsample
Blood Gas and Electrolyte Analyzer Market Trends:
The escalating number of patients in operating rooms, intensive care units (ICUs), and emergency departments is primarily driving the blood gas and electrolyte analyzer market. Furthermore, the increasing prevalence of chronic diseases among the geriatric population and the elevating demand for high throughput, integrated, and automated systems are acting as significant growth-inducing factors.
Additionally, the growing product usage with laboratory information systems and electronic medical records for streamlining the workflow and enabling effective monitoring of patient health is also positively influencing the market growth. Besides this, the inflating investments by key market players to develop portable product variants with easy-to-use features and minimum maintenance requirements and the shifting preferences toward point-of-care testing (POCT) are expected to propel the blood gas and electrolyte analyzer market over the forecasted period.
Global Blood Gas and Electrolyte Analyzer Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Major Players Covered:
- Abbott Laboratories Inc.
- Nova Biomedical Corporation
- OPTI Medical Systems Inc. (IDEXX Laboratories)
- Radiometer Medical ApS (Danaher Corporation)
- Roche Holding AG
- Dalko Diagnostics
- Erba Group (Transasia Bio-Medicals Ltd.)
- Medica Corporation
- Siemens AG
- WerfenLife S.A.
The report has segmented the market on the basis of product type, modality, end user and region.
Breakup by Product Type:
- Analyzers
- Consumables
Breakup by Modality:
- Benchtop
- Portable
Breakup by End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC List of Figure: https://www.imarcgroup.com/request?type=reportid=5786flag=C
Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
